A new government report adds to evidence that the HPV vaccine, once called dangerous by Health and Human Services Secretary Robert F. Kennedy Jr., is preventing cervical cancer in young women. The report comes after Kennedy pledged to give a family member any fees he might earn from HPV vaccine litigation.

The human papillomavirus (HPV) vaccine is having a huge impact on cervical cancer prevention among young women, a U.S. government report published Thursday suggests. Why it matters: The CDC report shows that rates of precancerous lesions among women aged 20-24 screened for cervical cancer dropped by about 80% from 2008 to 2022.

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually transmitted infection that affects both females and males and is linked to higher risks of various forms of cancer.

From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened for cervical cancer.

A new CDC report adds to evidence that the HPV vaccine, once called dangerous by HHS Secretary Robert F. Kennedy Jr., is preventing cervical cancer in young women.

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened for cervical cancer

New CDC data on falling rates of precancerous cervical lesions in the U.S. underscore the benefits of HPV vaccination.

A new CDC report finds that rates of precancerous lesions detected in women ages 20 to 24 have decreased by nearly 80%, lesions that would likely develop into cervical cancer years later.

A CDC report shows a dramatic drop in precancerous HPV lesions in young women. Here’s why the HPV vaccine is beneficial.

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting recommendations for HPV vaccination at ages 11 to 12 years, researchers wrote in Morbidity and Mortality Weekly Report.

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened for cervical cancer.

HPV vaccination efforts have significantly reduced the rates of precancerous cervical lesions among women, particularly those aged 20-24, showing an 80% decrease. Continued screening and prevention are essential,